A randomized, double-blind, placebo-controlled study of high-dose bosentan in patients with stage IV metastatic melanoma receiving first-line dacarbazine chemotherapy

- Kefford, Richard F., Clingan, Philip R., Brady, Benjamin, Ballmer, Andrea, Morganti, Adele, Hersey, Peter

Vitamin D receptor variants and the malignant melanoma risk: a population-based study

- Gapska, P., Scott, R. J., Maleszka, R., Sulikowski, M., Lubinski, J., Debniak, T., Serrano-Fernandez, P., Mirecka, A., Rassoud, I., Gorski, B., Cybulski, C., Huzarski, T., Byrski, T., Nagay, L.

Common variants of DNA repair genes and malignant melanoma

- Debniak, T., Scott, R. J., Kowalska, E., Jakubowska, A., Gronwald, J., Wokolorczyk, D., Maleszka, R., Kładny, J., Lubinski, J., Gorski, B., Cybulskia, C., van de Wetering, T., Serrano-Fernandez, P., Huzarski, T., Byrski, T., Nagay, L., Dębniak, B.

Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland

- Debniak, Tadeusz, van de Wetering, Thierry, Byrski, Tomasz, Nej-Wolosiak, Katarzyna, Kladny, Jozef, Maleszka, Romuald, Lubinski, Jan, Scott, Rodney, Nagay, Leszek, Cybulski, Cezary, Gorski, Bohdan, Jakubowska, Annaa, Gronwald, Jacek, Masojc, Bartlomiej, Huzarski, Tomasz